About the Authors
Leon E. Rosenberg
Leon E. Rosenberg has been a professor in the Department of Molecular Biology and the Woodrow Wilson School of Public and International Affairs at Princeton University since 1998. From September 1991 to January 1998, Rosenberg was Chief Scientific Officer of the Bristol-Myers Squibb Company.
Prior to joining Bristol-Myers Squibb, Rosenberg was dean of the Yale University School of Medicine, a position he had held since 1984. During his 26 year affiliation with Yale, he worked as a research geneticist, teacher, clinician, and administrator. In 1965, he was appointed assistant professor of medicine at Yale. He was named professor of human genetics, pediatrics, and medicine in 1972, the same year he helped establish the Department of Human Genetics at Yale and became its first chairman. A specialist in inherited metabolic disorders in children, Rosenberg and his colleagues conducted pioneering laboratory investigations into the molecular basis of several inherited disorders of amino acid and organic acid metabolism.
Rosenberg received his BA and MD degrees, both summa cum laude, from the University of Wisconsin. He completed his internship and one year of residency training in internal medicine at Columbia-Presbyterian Medical Center in New York City. After New York, he moved to Bethesda, Maryland, to begin a six-year association as an investigator with the metabolism service of the National Cancer Institute.
Dr. Rosenberg’s honors include election to the National Academy of Sciences and to the Institute of Medicine, recipient of the Borden Award from the American Academy of Pediatrics and of the Kober Medal from the Association of American Physicians, and honorary Doctor of Science degrees from the University of Wisconsin and the Mt. Sinai School of Medicine. Rosenberg was the medalist for the Australian Society for Medical Research in 2002. He is a past president of the American Society of Human Genetics, the Association of American Physicians, the Funding First Initiative of the Mary Lasker Trust, and the Association of Patient Oriented Research. Dr. Rosenberg is currently Chairman of the Board of Directors of HANA Biosciences, Inc. and Karo Bio AB, Medicines for Malaria Venture and serves on the Board of Directors of Lovelace Respiratory Research Institute.
Diane Drobnis Rosenberg
Diane Drobnis Rosenberg is the Chief Operating Officer of Meadowgate Farm Alpacas, LLC, in Lawrenceville, NJ. She has been active on numerous boards, including the Foundation for Health in Aging Board for the American Geriatrics Society, the Friends Board of the Institute for Advanced Study, and SAVE, a private Princeton animal shelter.
At companies such as McGraw-Hill, Elsevier Science Publishing, and Williams and Wilkins, Ms. Drobnis Rosenberg acquired and published life sciences books and texts as well as medical journals. In 1990, she started a consulting firm that worked with medical societies on business arrangements for their journals.
Ms. Drobnis Rosenberg was born in Washington, D.C. in 1944 and grew up in Evanston, Illinois. She is an Alumna of Wellesley College where she majored in Biology and also the University of Pennsylvania, where she studied Molecular Biology, having been awarded a NASA traineeship. She has four children and five grandchildren.